Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: Revealing the unforeseen

被引:18
作者
Bogdanos, Dimitrios-Petrou
Liaskos, Chris
Rigopoulou, Eirini I.
Liaskos, Chris
Dalekos, George N.
机构
[1] Kings Coll Hosp London, Inst Liver Studies, Liver Immunopathol, London SE5 9RS, England
[2] Univ Thessaly, Larissa Med Sch, Acad Liver Unit, Larisa, Greece
[3] Univ Thessaly, Larissa Med Sch, Res Lab Internal Med, Dept Internal Med, Larisa, Greece
关键词
autoimmunity; autoantibody; liver disease; indirect immunofluorescence;
D O I
10.1016/j.cca.2006.04.001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
引用
收藏
页码:183 / 184
页数:2
相关论文
共 9 条
[1]
Bogdanos Dimitrios-Petrou, 2003, Clin Liver Dis, V7, P759, DOI 10.1016/S1089-3261(03)00104-1
[2]
Specificity of anti-sp100 antibody for primary biliary cirrhosis [J].
Bogdanos, DP ;
Vergani, D ;
Muratori, P ;
Muratori, L ;
Bianchi, FB .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (04) :405-406
[3]
Medical progress: Primary biliary cirrhosis [J].
Kaplan, MM ;
Gershwin, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) :1261-1273
[4]
Increased serum aminotransferases associated with anti-mitochondrial antibodies in systemic lupus erythematosus patients with autoimmune liver disease [J].
Li, CH ;
Xu, PS ;
Wang, CY ;
Zou, GL .
CLINICA CHIMICA ACTA, 2006, 365 (1-2) :135-142
[5]
Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis:: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals [J].
Lohse, AW ;
zum Büschenfelde, KHM ;
Franz, B ;
Kanzler, S ;
Gerken, G ;
Dienes, HP .
HEPATOLOGY, 1999, 29 (04) :1078-1084
[6]
Natural history of early primary biliary cirrhosis [J].
Metcalf, JV ;
Mitchison, HC ;
Palmer, JM ;
Jones, DE ;
Bassendine, MF ;
James, OFW .
LANCET, 1996, 348 (9039) :1399-1402
[7]
Vergani D, 2003, AM J GASTROENTEROL, V98, P241
[8]
Vergani Diego, 2002, Clin Liver Dis, V6, P727, DOI 10.1016/S1089-3261(02)00018-1
[9]
Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases [J].
Zachou, K ;
Liaskos, C ;
Rigopoulou, E ;
Gabeta, S ;
Papamichalis, P ;
Gatselis, N ;
Georgiadou, S ;
Dalekos, GN .
CLINICAL IMMUNOLOGY, 2006, 119 (02) :203-212